Since the trial I have been able to keep living life how I want to

Peter, 84, lives with mesothelioma, a rare and aggressive cancer of the lining of the lungs. This year he took part in a pioneering trial to see if a new type of radiotherapy could revolutionise its treatment.

“In September 2025, I was told I had mesothelioma.

My children told me to go and see the doctors because I was struggling with my breathing and couldn’t stop coughing.

Originally, I was diagnosed with COPD, and it took a couple of months to determine I also had mesothelioma. I had an X-ray, and after a week they called me for another one and then a CT scan. I had thought to myself during this that it was probably cancer, so I had already started to accept it.

The consultant sat me down and started explaining things and I asked, ‘Do I have cancer?’ and she told me ‘Yes’.”

The trial was the best Christmas present I could have hoped for

The blood drained from me at first. I felt shocked, of course, but almost straight away I went into practical mode: right, let’s deal with it. My thoughts were just ‘ok where do we go from here?’

Unfortunately, surgery wasn’t an option, and neither chemotherapy nor standard radiotherapy would be suitable because the cancer was too near my heart. But four or five weeks after my diagnosis we started speaking about a new trial using proton beam therapy. I said yes immediately, and I was accepted onto the trial a few days before Christmas. It was the best Christmas present I could have hoped for.

I'm not as active, but I'm still able to do the things I enjoy

I joined the trial in February 2026. My wife and I stayed in London for 6 weeks while I took part because I was in the hospital every day receiving the proton beam therapy. I felt reassured from the start of the trial and throughout. Everyone was phenomenal and so supportive.

There were some small side effects, but these were all explained to me, and the staff helped me through it with care. Since the trial, I have been able to keep living life how I want to. Not as active as I was, but I can still go fishing and do the country sports that I enjoy, I’m just slower! I need to have fluid drained from around my lungs every other day, but a nurse comes to my home to help with this, so it doesn’t bother me too much. I’d rather do this and still be alive.”

This trial could bring new hope for mesothelioma

The trial, funded by Asthma + Lung UK, is the first of its kind to investigate proton beam therapy as a potential treatment for mesothelioma. Dr Crispin Hiley, who is leading the project, says, “We want to not only help people to live longer, but to live better. Through this trial, we hope to show that this approach can significantly improve survival and quality of life for patients. If successful, it could fundamentally change how mesothelioma is treated in the UK.” Dr Hiley tells us more about his pioneering research in his blog.

You may also like

An image of Dr Crispin Hiley
Research

Shining new light on treatment for people with mesothelioma

Mesothelioma is one of the most difficult cancers to treat, with a poor survival rate. Dr Crispin Hiley at University College London is investigating whether a new type of radiotherapy could revolutionise its treatment.
A man with short grey hair, a blue and white polo shirt and blue jeans is stood in front of a railing with the sea in the background.
Your stories

It’s always there but I refuse to let it ruin my mental health

David, a father of three, was diagnosed with mesothelioma in November 2019. He noticed that he was getting more breathless than usual.
A man with a black hat and a blue fleece is stood on a hill.
Your stories

Losing my loved ones to mesothelioma – how fundraising has helped me

After experiencing devastating loss, losing his wife, mother, and brother to mesothelioma, 76-year-old Ray started fundraising for Asthma + Lung UK. Here, he tells us his story about how doing a challenge has helped him to cope with his loss, and how he’s fundraised over £13,300 in aid of mesothelioma support and research.